The biotechnology company's potential coronavirus vaccine moved into the next phase of development. Unity Biotechnology Inc., down $8.28 to $4.15.
News
- Principia, Novavax rise; Wells Fargo, Carnival fall
- Op-Ed: Trump pushing untested Covid-19 treatment touted by MyPillow CEO
Phoenix Biotechnology engages in the research and development of ... The company was incorporated in 2003 and is based in San Antonio, Texas.
- UTSA to unveil its new Science and Engineering building on Saturday
SAN ANTONIO - One San Antonio University is about to expand its research ... “No matter their career aspiration—research scientist, biotech worker, ...
- The ethical case for allowing medical trials that deliberately infect humans with COVID-19
Back in May, leading developers of potential COVID-19 vaccines, including the biotechnology company Moderna and Oxford University, issued a ...
- Dillard's, Novavax rise; Baidu, DraftKings fall
The biotechnology company signed a deal to provide 60 million doses of a COVID-19 vaccine it's developing to the U.K.. Purple Innovation Inc., down ...